What question did this study set out to answer?

The study aims to examine how D-chiro-inositol modulates insulin signaling and impacts neuroinflammation and cognitive decline in Alzheimer's disease.

June 19, 2026Biomedicine & PharmacotherapyOpen Access

D-chiro-inositol modulates brain insulin-related signaling and reduces amyloid burden, neuroinflammation and cognitive decline in preclinical models of Alzheimer's disease

View Full Paper

Ask AI

Bookmark

The study aims to examine how D-chiro-inositol modulates insulin signaling and impacts neuroinflammation and cognitive decline in Alzheimer's disease.
Utilized primary neurons from App NL-G-F knock-in mice, SH-SY5Y cells, and 5xFAD mouse models.
Assessed toxicity, pharmacokinetics, and pharmacodynamics of D-chiro-inositol.
Chronic oral administration of D-chiro-inositol was performed in vivo.
D-chiro-inositol significantly reduced hippocampal amyloid burden in vivo.
It improved systemic glucose handling and enhanced insulin receptor activation.
Chronic treatment rescued recognition memory and normalized risk-assessment behavior.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Randomized trial investigates D-chiro-inositol's effects on amyloid burden and cognitive function in preclinical Alzheimer's disease models, indicating therapeutic potential.

Cite This Study

Pacheco-Sánchez et al. (2026) studied this question.

synapsesocial.com/papers/6a34de1265a5b0777af2d917 https://doi.org/10.1016/j.biopha.2026.119629

View Full Paper

Ask AI

Bookmark

Implication

Randomized trial investigates D-chiro-inositol's effects on amyloid burden and cognitive function in preclinical Alzheimer's disease models, indicating therapeutic potential.

D-chiro-inositol modulates brain insulin-related signaling and reduces amyloid burden, neuroinflammation and cognitive decline in preclinical models of Alzheimer's disease

Key Points

Discussion

Implication

Cite This Study

D-chiro-inositol modulates brain insulin-related signaling and reduces amyloid burden, neuroinflammation and cognitive decline in preclinical models of Alzheimer's disease

Key Points

Discussion

Implication

Cite This Study

Keep reading

Keep reading